255
video
December 8 at 2:00 pm EST | Is Long COVID the Next Public Health Emergency?
The long-term debilitating effects of COVID-19 on people infected with the SARS-CoV-2 virus are a
serious concern for clinicians, researchers and policymakers.
+ Read More
video
December 8 at 4 pm EST | Closing Plenary: The Future of Food and Health Part 2: A Conversation with Secretary of Agriculture Tom Vilsack
Guest
Tom Vilsack
Secretary, US Department of Agriculture
video
December 6 at 10:30 am EST | Accelerating Access to Lifesaving Treatments and Cures: Insights from FDA's Expedited Review Programs
The Food and Drug Administration's (FDA) expedited review processes have been instrumental in maki
ng treatments available for individuals living with serious illnesses.
+ Read More
video
December 6 at 10:30 am EST | Foundations as Trusted Intermediaries for Patient Data Resources
Analyzing data from and about patients is essential to advance biomedical research, but its collec
tion and dissemination require significant investment of time and resources for patient organizations that choose to be the intermediary.
+ Read More
video
December 6 at 12:30 pm EST | The Path Forward for Patient-Focused Product Development and Use of Patient Input in Decision-Making
Consideration of patients' needs, experiences, and perspectives can contribute to medical product
development processes, as well as inform regulatory and access decision-making.
+ Read More
video
December 6 at 12:30 pm EST | Why Is It Still So Hard for People to Get Their Health Data?
Patients are the source, active or passive, of most of the data driving discovery and innovation i
n biomedical R&D and improvements in care.
+ Read More
video
December 6 at 2:00 pm EST | Improving Health Equity in Rare Diseases Research
People with rare diseases face many barriers and inequities in accessing diagnosis, treatment, and
comprehensive care. This burden is even greater among marginalized communities with rare diseases.
+ Read More
video
December 6 at 2:00 pm EST | Innovation in Biomarker Development and Deployment
Validated biomarkers are an essential and often under-appreciated tool for detecting and treating
diseases, improving drug development, and informing regulatory decision making.
+ Read More
video
December 6 at 3:30 pm EST | Time=Lives and Building the Clinical Trial Enterprise of the Future
This session will open with a Time=Lives Talk by Casey McPherson, Co-Founder and Chief Innovation
Officer, Everlum Bio and Founder and President, To Cure A Rose Foundation, followed by a panel discussion on Building the Clinical Trial Enterprise of the
+ Read More
video
December 6 at 3:30 pm EST | Time=Lives and Overcoming Challenges to Drug Repurposing
New drugs can take more than a decade to develop and get to market.
video
December 6 at 5:00 pm EST | Long COVID: A Conversation with US Senator Tim Kaine
Guest
Tim Kaine
US Senator, Virginia
video
December 6 at 7:15 pm EST | Future of Health Summit Dinner | A Commitment to Accelerating Cures: The Future of Biomedical Innovation
The new year will begin with fresh leadership at several of the nation's top scientific agencies.
Hear from Dr. Bertagnolli and Dr.
+ Read More